SpringWorks Therapeutics, Inc. Business Operations Contracts & Agreements
8 Contracts & Agreements
- Collaboration Agreements (3 contracts)
- Indemnification Agreements (2)
- Sales Agreements (2)
- Termination Agreements (1)
- Sales Agreement, dated February 27, 2024, by and between SpringWorks Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on February 27, 2024)
- Amendment No. 1 dated October 22, 2021, to the Clinical Trial Collaboration and Supply Agreement, dated as of June 25, 2019, between GlaxoSmithKline LLC and SpringWorks... (Filed With SEC on October 27, 2021)
- Sales Agreement, dated February 25, 2021, by and between SpringWorks Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on February 25, 2021)
- Termination Letter by and between SpringWorks Therapeutics Operating Company, Inc. and Daniel S. Lynch, dated August 16, 2019 (Filed With SEC on September 3, 2019)
- Clinical Trial Collaboration and Supply Agreement by and between the Registrant and GlaxoSmithKline LLC, dated June 25, 2019 (Filed With SEC on August 16, 2019)
- Clinical Collaboration Agreement by and among Springworks Subsidiary 3, PBC and BeiGene, Ltd., dated August 16, 2018 (Filed With SEC on August 16, 2019)
- Form of Indemnification Agreement, by and between the Registrant and each of its Officers (Filed With SEC on August 16, 2019)
- Form of Indemnification Agreement, by and between the Registrant and each of its Directors (Filed With SEC on August 16, 2019)